Cohance Lifesciences receives ESG rating of 61

Cohance Lifesciences announced that Crisil ESG Ratings has voluntarily assigned an ESG Rating of ?Crisil ESG 61 (Strong)? and Core ESG Rating of ?Crisil Core ESG 67 (Strong)? to the Company.